Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Influenza A virus hemagglutinin (HA) head trimer interface epitope is a highly conserved site located within the globular head domain of the HA protein, which is typically occluded in the native, pre-fusion trimeric conformation. Unlike the immunodominant head regions that undergo rapid antigenic drift, the residues at the trimer interface are relatively stable across diverse influenza strains, making them an attractive target for broadly neutralizing antibodies (bnAbs). These antibodies, such as FluA-20, function by recognizing the epitope when the HA head domains transiently 'breathe' or dissociate, subsequently preventing the structural rearrangements necessary for viral-host membrane fusion. By targeting this hidden site, therapeutics can achieve cross-reactivity against multiple subtypes of Influenza A, including both Group 1 and Group 2 viruses. This epitope represents a significant shift in vaccine and monoclonal antibody design, moving away from the highly variable receptor-binding site toward more conserved, functionally critical structural regions of the virus.
Antibodies targeting this epitope bind to the normally occluded interface between the globular head domains of the hemagglutinin trimer, leading to trimer dissociation or preventing the conformational changes required for viral membrane fusion and entry into the host cell.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza A virus hemagglutinin head trimer interface epitope (HA head trimer interface).